News

  • Weeding out childhood leukaemia – fighting cancer with nature 31 May 2018 New research, led by cancer biologists from the University of Bristol, has shown that bone marrow cells can protect cancer cells from a plant derived anti-cancer agent called Parthenolide.
  • New evidence on link between obesity and smoking behaviour from genetic data: obese people at higher risk of smoking 25 May 2018 A study by the International Agency for Research on Cancer (IARC) provides new evidence that increased weight and obesity may result in increased smoking. The Cancer Research UK (CRUK)-funded study, involving University of Bristol researchers and published today in the British Medical Journal (BMJ), found that increased body mass index (BMI), body fat percentage, and waist circumference were associated both with a higher risk of being a smoker and with greater smoking intensity, measured by the number of cigarettes smoked per day. These results were consistent in both men and women.
  • Can a home WiFi router act as a medical sensing device? 10 May 2018 New research that could transform the future of healthcare will investigate whether it is possible to reuse WiFi radio waves as a medical radar system. The research, led by the University of Bristol, is part of a new £1.5 million grant awarded by the Engineering and Physical Sciences Research Council (EPSRC), Toshiba and Decawave to the OPERA project, a consortium including the universities of Bristol and Oxford; University College London and Coventry University.
  • EBI funded project awarded further funds to continue prehabilitation work for cancer patients 9 May 2018 Thanks to initial funding from University of Bristol’s Elizabeth Blackwell Institute we are now close to seeing some real impact from a prehabilitation intervention for cancer patients undergoing major surgery. The project, which aims to identify interventions that improve post-operative recovery, has been awarded further funding to take forward this important research.
  • New CEO of Cancer Research UK 4 May 2018 Michelle Mitchell OBE has been appointed as CEO of Cancer Research UK. She will replace Sir Harpal Kumar who is due to stand down in the summer.
  • Screening and treatment for prostate cancer: two trials address the controversies 19 April 2018 Jenny Donovan, Professor of Social Medicine, University of Bristol and Director of the NIHR Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) on the recent findings from two large prostate cancer trials that she has led.
  • Collaborative research to improve health and care 18 April 2018 Scientists are collaborating with NHS and public health staff to ensure that research evidence is used effectively to improve public health and patient outcomes. Professor Jenny Donovan, NIHR CLAHRC West Director, and Lara Edwards, NIHR CLAHRC West Manager, explain why collaboration is so important and offer some examples of the benefits it brings.
  • Outpatient treatment for cancer condition offers effective new approach for patients 5 April 2018 A novel approach to treating fluid build-up around the lungs of cancer patients could deliver a more effective home-based treatment for thousands of people who might be approaching the end of their lives, according to a new study led by the University of Bristol and North Bristol NHS Trust.
  • Bristol scientists behind the largest trial ever to investigate prostate cancer screening 12 March 2018 Inviting men with no symptoms to a one-off PSA* test for prostate cancer does not save lives according to results from the largest ever trial conducted by Cancer Research UK-funded scientists based at the University of Bristol.
  • Bristol Bladder trial 21 February 2018 A Phase II Trial of combination Cabazitaxel and Cisplatin Chemotherapy in the Neoadjuvant Treatment of Transitional Cell Carcinoma of the Urinary Bladder.

Cancer research press releases

Press releases relating to cancer research on the University's central news pages.

Years iterator 20182017201620152014
View all news
Edit this page